Don Berwick

Berwick, Don

Donald M. Berwick, MD, MPP, FRCP is president emeritus and senior fellow at the Institute for Healthcare Improvement (IHI), an organization that Dr. Berwick co-founded and led as president and CEO for 18 years. He is one of the nation’s leading authorities on health care quality and improvement.

Read MoreRead Less

Troy Brennan

Brennan, Troy

Troyen A. Brennan, M.D., M.P.H. is executive vice president and chief medical officer of CVS Caremark.

Prior to joining CVS Caremark, Dr. Brennan was Chief Medical Officer of Aetna Inc. From 2000 to 2005, Dr. Brennan served as President and CEO of Brigham and Women’s Physician’s Organization. In his academic work, he was professor of medicine at Harvard Medical School, and professor of law and public health at Harvard School of Public Health.

Read MoreRead Less

Andrew Dreyfus

Dreyfus, Andrew

Andrew Dreyfus is president and chief executive officer for Blue Cross Blue Shield of Massachusetts. Serving nearly 3 million members, BCBSMA is one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country. As CEO, Dreyfus leads the company’s effort to make quality health care affordable.

Read MoreRead Less

David Ebersman

Ebersman, David

David Ebersman was most recently the chief financial officer of Facebook, where he led the finance, facilities and information technology teams.


Read MoreRead Less

Mala Gaonkar

Gaonkar, Mala

Mala Gaonkar, M.B.A. is co-portfolio manager at investment firm Lone Pine Capital LLC, a role she has held since 1998. After graduating in economics at Harvard in 1991, she worked for The Boston Consulting Group, primarily in Munich and Hong Kong and completed her MBA at Harvard Business School before Lone Pine’s inception.

Read MoreRead Less

Peter Hecht


Peter Hecht, Ph.D has served as Ironwood’s CEO and a director since co‐founding the company in 1998. He started Ironwood because he was attracted to “the idea of working with a team of people who challenge, inspire and humble me,” and building an enduring organization dedicated to creating important medicines.

Read MoreRead Less

Eric S. Lander

Lander, Eric

Eric Lander, Ph.D. is the founding director and serves as a core member of the Broad Institute of MIT and Harvard. One of the principal leaders of the Human Genome Project, he and his colleagues have a long-standing interest in applying genomics to understand the molecular basis of human physiology and disease.

Read MoreRead Less

Elizabeth Nabel

Nabel, Elizabeth

Elizabeth Nabel, M.D. is the president of Brigham and Women’s Health Care (BWHC), comprised of BWH and Brigham and Women’s Faulkner Hospital. Prior to her position at BWHC, Dr. Nabel served as the director of the National Heart, Lung, and Blood Institute at the National Institutes of Health. In this capacity, Dr. Nabel oversaw an extensive national research portfolio with an annual budget of approximately $3 billion to prevent, diagnose, and treat heart, lung, and blood diseases.

Read MoreRead Less

Michelle Williams


Michelle Williams, ScD, SM, MS, is the Dean of Harvard T.H. Chan School of Public Health. Prior to her appointment as Dean, Williams was the chair of the Epidemiology Department and a Stephen B. Kay Family Professor of Public Health and Global Health and Population at the Harvard T.H. Chan School of Public Health. She has received countless awards for her work including the Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring.

Read MoreRead Less

Jason Yeung

Yeung, Jason (Tony Rinaldo)

Jason Yeung, M.Phil. is a managing director and portfolio manager at Morgan Stanley with a focus on Investment Management Growth Funds. He has been employed at Morgan Stanley since 2002. His career has focused on investments in the healthcare space. He also serves as a board member of Lifebox Foundation Inc. and co-chair of the Young Partners Board of the Public Theater of New York City.

Read MoreRead Less

Gwill York

York, Gwill LG

Gwill York, MBA, is a pioneering entrepreneur with 30 years of experience financing early-stage technology and healthcare companies.  Gwill co-founded Lighthouse Capital Partners in 1994, a structured venture capital partnership based in Cambridge and Menlo Park.  At Lighthouse, she led investments in companies such as Vertex Pharmaceuticals, Millennium Pharmaceuticals, Cascade Communications, Sirocco Systems, Speechworks, Storage Networks and Netflix.

Read MoreRead Less